News

Prediction: $10,000 Equally Split Between Eli Lilly and Novo Nordisk Will Be Worth This Much by the End of 2027

NASDAQ

Key PointsEli Lilly is surging, with revenue up 39% in the third quarter and a retatrutide filing planned for early 2027.

Read the full Veytics brief

We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.